Phase II trial with oral idarubicin in advanced breast cancerMassimo Lopez, Nicola Di Pietro, Fabrizio Ganzina et al.|Investigational New Drugs|1986Cited by 27
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaGiorgio Lambertenghi‐Deliliers, E. Polli, Enrico Pogliani et al.|European Journal of Cancer and Clinical Oncology|1987Cited by 19
Phase II study of epirubicin in advanced malignant melanomaMassimo Lopez, Aldo Barduagni, Carlo Federico Perno et al.|Investigational New Drugs|1984Cited by 13
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanomaMassimo Lopez, Aldo Barduagni, Carlo Federico Perno et al.|Investigational New Drugs|1984Cited by 13
Epirubicin in non-Hodgkinʼs lymphomasMassimo Lopez, Nicola Di Pietro, Luigi Di Lauro et al.|American Journal of Clinical Oncology|1985Cited by 11